Search

everythinglearnresearchcommunity

for

Search:↓

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

A clinically suspected melanoma appeared benign under the microscope but was confirmed by specific tests and a rare mutation.

Melanogenesis inhibitors like kojic acid and niacinamide can reduce inflammation and pigment production in skin cells.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

Removing both KLK5 and KLK7 proteins can prevent death and skin issues in Netherton syndrome.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Miliacin helps damaged hair follicles grow new hair faster.

Wedelolactone may help treat lung fibrosis by reducing inflammation and lung damage.

Pimecrolimus reduces the effectiveness of stem cell therapy for atopic dermatitis.

OR-101 shows promise for treating alopecia areata by improving hair growth.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

JAK inhibitors show promise in treating skin conditions like eczema, hair loss, and vitiligo but need more safety research.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

Potassium channel openers like minoxidil boost hair growth.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

JAK inhibitors help regrow hair in alopecia areata, but their long-term safety is still unclear.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

MC-DNA vector-based gene therapy can temporarily treat CBS deficiency in mice.